Analyst Reco. Moderna, Inc.

Equities

MRNA

US60770K1079

Market Closed - Nasdaq Other stock markets 04:00:01 2024-05-31 pm EDT			5-day change	1st Jan Change
142.6 ^USD	-5.89%		-14.43%	+43.36%

May. 31	Health Care Stocks Climb On Drug News -- Health Care Roundup	DJ
May. 31	Equities Mostly Rise as Fed's Preferred Inflation Measure Meets Street Views	MT

Analyst Reco.

Unlock all the news: Be the first to know and act before the market!

100% Free Registration

RBC Raises Moderna's Price Target to $160 From $135	May. 31	MT
Moderna Insider Sold Shares Worth $1,909,863, According to a Recent SEC Filing	May. 20	MT
Moderna Insider Sold Shares Worth $1,912,350, According to a Recent SEC Filing	May. 17	MT
Arbutus Biopharma Urged to Stop Share Issuances, Explore Alternatives for Hepatitis B Program	May. 17	MT
ANALYST RECOMMENDATIONS : Nike, Roblox, Starbucks, Walmart, Deckers Outdoor...	May. 14
Evercore ISI Initiates Moderna With In Line Rating, $120 Price Target	May. 14	MT
Moderna Insider Sold Shares Worth $1,825,220, According to a Recent SEC Filing	May. 13	MT
Deutsche Bank Raises Moderna's Price Target to $85 From $70	May. 09	MT
UBS Adjusts Moderna Price Target to $151 From $143, Maintains Buy Rating	May. 07	MT
News Highlights : Top Financial Services News of the Day - Monday at 11 AM ET	May. 06	DJ
Moderna Insider Sold Shares Worth $1,663,855, According to a Recent SEC Filing	May. 06	MT
Jefferies Adjusts Price Target on Moderna to $155 From $125	May. 03	MT
Oppenheimer Adjusts Price Target on Moderna to $163 From $142	May. 03	MT
Goldman Sachs Adjusts Price Target on Moderna to $204 From $206	May. 03	MT
Leerink Adjusts Price Target on Moderna to $60 From $59	May. 03	MT
Morgan Stanley Adjusts Price Target on Moderna to $95 From $89	May. 03	MT
Jefferies & Co Adjusts Moderna Price Target to $155 From $125	May. 03	MT
Goldman Sachs Adjusts Moderna Price Target to $204 From $206	May. 03	MT
Morgan Stanley Raises Price Target on Moderna to $95 From $89, Keeps Equalweight Rating	May. 03	MT
RBC Raises Price Target on Moderna to $135 From $125 on 'More Prudent Financial Outlook,' Keeps Outperform Rating	May. 03	MT

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Headlines

Moderna, Inc. prepares for the post-Covid era

March 25, 2024 at 10:24 am EDT

Stéphane Bancel, CEO of Moderna: Restoring confidence in the vaccines sector

January 16, 2024 at 03:31 pm EST